In vivo priming of human mesenchymal stem cells with hepatocyte growth factor–engineered mesenchymal stem cells promotes therapeutic potential for cardiac repair

The clinical use of human bone marrow–derived mesenchymal stem cells (BM-MSCs) has been hampered by their poor performance after transplantation into failing hearts. Here, to improve the therapeutic potential of BM-MSCs, we developed a strategy termed in vivo priming in which BM-MSCs are primed in v...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Sci Adv
Main Authors: Park, Bong-Woo, Jung, Soo-Hyun, Das, Sanskrita, Lee, Soon Min, Park, Jae-Hyun, Kim, Hyeok, Hwang, Ji-Won, Lee, Sunghun, Kim, Hyo-Jin, Kim, Hey-Yon, Jung, Seungman, Cho, Dong-Woo, Jang, Jinah, Ban, Kiwon, Park, Hun-Jun
פורמט: Artigo
שפה:Inglês
יצא לאור: American Association for the Advancement of Science 2020
נושאים:
Research Articles
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7141892/
https://ncbi.nlm.nih.gov/pubmed/32284967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciadv.aay6994
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים